P. Hallenbeck

发表

Potentiation of oncolytic adenoviral vector efficacy with gutless vectors encoding GMCSF or TRAIL

K. Burroughs, D. Kayda, K. Sakhuja, 2004, Cancer Gene Therapy.

DNA binding and heteromerization of the Drosophila transcription factor chorion factor 1/ultraspiracle.

F. Kafatos, P. Hallenbeck, E. Hatzivassiliou, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Roles of CfxA, CfxB, and external electron acceptors in regulation of ribulose 1,5-bisphosphate carboxylase/oxygenase expression in Rhodobacter sphaeroides

P. Hallenbeck, S. Kaplan, R. Lerchen, 1990, Journal of bacteriology.

Phosphoribulokinase activity and regulation of CO2 fixation critical for photosynthetic growth of Rhodobacter sphaeroides

P. Hallenbeck, S. Kaplan, R. Lerchen, 1990, Journal of bacteriology.

Structure of Seneca Valley Virus-001: an oncolytic picornavirus representing a new genus.

P. Hallenbeck, V. Reddy, N. Idamakanti, 2008, Structure.

H‐2RIIBP (RXR beta) heterodimerization provides a mechanism for combinatorial diversity in the regulation of retinoic acid and thyroid hormone responsive genes.

E. Appella, K. Ozato, M. Marks, 1992, The EMBO journal.

Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression.

S. Kaneko, W. Anderson, Y. Chiang, 1995, Cancer research.

Antitumor efficacy and tumor-selective replication with a single intravenous injection of OAS403, an oncolytic adenovirus dependent on two prevalent alterations in human cancer

Ying Huang, P. Ryan, J. Jakubczak, 2004, Cancer Gene Therapy.

Systemic gene-directed enzyme prodrug therapy of hepatocellular carcinoma using a targeted adenovirus armed with carboxypeptidase G2.

C. Springer, R. Marais, F. Friedlos, 2005, Cancer research.

Intravenous injection of oncolytic picornavirus SVV-001 prolongs animal survival in a panel of primary tumor-based orthotopic xenograft mouse models of pediatric glioma.

C. Lau, M. Chintagumpala, R. Hurwitz, 2013, Neuro-oncology.

Heterodimerization of thyroid hormone (TH) receptor with H-2RIIBP (RXR beta) enhances DNA binding and TH-dependent transcriptional activation.

K. Ozato, M. Marks, P. Hallenbeck, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Targetable gene delivery vectors.

P. Hallenbeck, S. Stevenson, 2000, Advances in experimental medicine and biology.

Characterization of myelin basic protein thyroid hormone response element and its function in the context of native and heterologous promoter.

P. Hallenbeck, B. Desvergne, A. Farsetti, 1992, The Journal of biological chemistry.

Crystallization and preliminary X-ray diffraction studies of Seneca Valley virus-001, a new member of the Picornaviridae family.

P. Hallenbeck, V. Reddy, N. Idamakanti, 2008, Acta crystallographica. Section F, Structural biology and crystallization communications.

Differential 9-cis-Retinoic Acid-dependent Transcriptional Activation by Murine Retinoid X Receptor (RXR) and RXR

S. Minucci, K. Ozato, P. Hallenbeck, 1996, The Journal of Biological Chemistry.

Differential 9-cis-retinoic acid-dependent transcriptional activation by murine retinoid X receptor alpha (RXR alpha) and RXR beta. Role of cell type and RXR domains.

S. Minucci, K. Ozato, P. Hallenbeck, 1996, The Journal of biological chemistry.

Evolving role of seneca valley virus and its biomarker TEM8/ANTXR1 in cancer therapeutics

P. Hallenbeck, P. Rychahou, Virginia Corbett, 2022, Frontiers in Molecular Biosciences.

Enhanced Gene Transfer to Rabbit Jugular Veins by an Adenovirus Containing a Cyclic RGD Motif in the HI Loop of the Fiber Knob

J. Jakubczak, P. Hallenbeck, S. Stevenson, 2001, Journal of Vascular Research.

Complete genome sequence analysis of Seneca Valley virus-001, a novel oncolytic picornavirus.

P. Hallenbeck, N. Knowles, C. Hay, 2008, The Journal of general virology.

Seneca Valley Virus, a Systemically Deliverable Oncolytic Picornavirus, and the Treatment of Neuroendocrine Cancers

C. Rudin, D. N. Watkins, K. Burroughs, 2007, Journal of the National Cancer Institute.

A single intravenous injection of oncolytic picornavirus SVV-001 eliminates medulloblastomas in primary tumor-based orthotopic xenograft mouse models.

X. Tan, Jianhua Yang, M. Chintagumpala, 2011, Neuro-oncology.

An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.

Ying Huang, P. Ryan, J. Jakubczak, 2003, Cancer research.

Antiangiogenic gene therapy for cancer via systemic administration of adenoviral vectors expressing secretable endostatin.

C. Schnell, J. Jakubczak, P. Hallenbeck, 2000, Human gene therapy.

A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma.

Y. Chiang, P. Hallenbeck, C. Hay, 1999, Human gene therapy.

Structural features of the Seneca Valley virus internal ribosome entry site element ; 2 a picornavirus with a pestivirus-like IRES 3 4

K. Burroughs, P. Hallenbeck, G. Belsham, 2013 .

Structural Features of the Seneca Valley Virus Internal Ribosome Entry Site (IRES) Element: a Picornavirus with a Pestivirus-Like IRES

K. Burroughs, P. Hallenbeck, G. Belsham, 2011, Journal of Virology.

Adenovirus Type 5 Viral Particles Pseudotyped with Mutagenized Fiber Proteins Show Diminished Infectivity of Coxsackie B-Adenovirus Receptor-Bearing Cells

G. Nemerow, M. Rollence, J. Jakubczak, 2001, Journal of Virology.

Characterization of a full-length infectious cDNA clone and a GFP reporter derivative of the oncolytic picornavirus SVV-001.

C. Rudin, K. Burroughs, P. Hallenbeck, 2012, The Journal of general virology.

Cloning of the gene for phosphoribulokinase activity from Rhodobacter sphaeroides and its expression in Escherichia coli

P. Hallenbeck, S. Kaplan, 1987, Journal of bacteriology.

Phase I Clinical Study of Seneca Valley Virus (SVV-001), a Replication-Competent Picornavirus, in Advanced Solid Tumors with Neuroendocrine Features

C. Rudin, N. Senzer, K. Burroughs, 2011, Clinical Cancer Research.

Divergent effects of 9-cis-retinoic acid receptor on positive and negative thyroid hormone receptor-dependent gene expression.

P. Hallenbeck, V. Nikodem, M. Phyillaier, 1993, The Journal of biological chemistry.

Phase I Clinical Study of Seneca Valley Virus (SVV-001), a Replication-Competent Picornavirus, in Advanced Solid Tumors with Neuroendocrine Features

C. Rudin, N. Senzer, K. Burroughs, 2011, Clinical Cancer Research.

Structure of Seneca Valley Virus-001: an oncolytic picornavirus representing a new genus.

P. Hallenbeck, V. Reddy, N. Idamakanti, 2008, Structure.